AbbVie (ABBV) IV into FDA decision on Rinvoq
Go back to AbbVie (ABBV) IV into FDA decision on Rinvoq| AbbVie (NYSE: ABBV) | Delayed: 243.80 -1.3 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $245.10 | 52 Week High | $68.12 | |||
| Open | $246.74 | 52 Week Low | $50.71 | |||
| Day High | $246.91 | P/E | 52.89 | |||
| Day Low | $242.39 | EPS | $4.61 | |||
| Volume | 8,028,608 | |||||
